Andrew J Epstein1, Lin Yang1, Feifei Yang1, Peter W Groeneveld2. 1. From the Department of Veterans Affairs' Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs Medical Center, PA (A.J.E., P.W.G.); Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (A.J.E., L.Y., F.Y., P.W.G.); and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia (A.J.E., P.W.G.). 2. From the Department of Veterans Affairs' Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs Medical Center, PA (A.J.E., P.W.G.); Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (A.J.E., L.Y., F.Y., P.W.G.); and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia (A.J.E., P.W.G.). petergro@upenn.edu.
Abstract
BACKGROUND: The Centers for Medicare and Medicaid Services require hospitals performing carotid artery stenting (CAS) to recertify the quality of their programs every 2 years, but currently this involves no explicit comparisons of postprocedure mortality across hospitals. Hence, the current recertification process may fail to identify hospitals that are performing poorly in relation to peer institutions. Our objective was to compare risk-standardized procedural outcomes across US hospitals that performed CAS and to identify hospitals with statistically high postprocedure mortality rates. METHODS AND RESULTS: We conducted a retrospective cohort study of Medicare beneficiaries who underwent CAS from July 2009 to June 2011 at 927 US hospitals. Thirty-day risk-standardized mortality rates were calculated using the Hospital Compare statistical method, a well-validated hierarchical generalized linear model that included both patient-level and hospital-level predictors. Claims were examined from 22 708 patients undergoing CAS, with a crude 30-day mortality rate of 2.0%. Risk-standardized 30-day mortality rates after CAS varied from 1.1% to 5.1% (P<0.001 for the difference). Thirteen hospitals had risk-standardized mortality rates that were statistically (P<0.05) higher than the national mean. Conversely, 5 hospitals had risk-standardized mortality rates that were statistically (P<0.05) lower than the national mean. CONCLUSIONS: We used administrative claims to identify several CAS hospitals with excessively high 30-day mortality after carotid stenting. When combined with information currently used by Medicare for CAS recertification, such as clinical registry data and program reports, clinical outcomes comparisons could enhance Medicare's ability to identify hospitals that are questionable candidates for recertification.
BACKGROUND: The Centers for Medicare and Medicaid Services require hospitals performing carotid artery stenting (CAS) to recertify the quality of their programs every 2 years, but currently this involves no explicit comparisons of postprocedure mortality across hospitals. Hence, the current recertification process may fail to identify hospitals that are performing poorly in relation to peer institutions. Our objective was to compare risk-standardized procedural outcomes across US hospitals that performed CAS and to identify hospitals with statistically high postprocedure mortality rates. METHODS AND RESULTS: We conducted a retrospective cohort study of Medicare beneficiaries who underwent CAS from July 2009 to June 2011 at 927 US hospitals. Thirty-day risk-standardized mortality rates were calculated using the Hospital Compare statistical method, a well-validated hierarchical generalized linear model that included both patient-level and hospital-level predictors. Claims were examined from 22 708 patients undergoing CAS, with a crude 30-day mortality rate of 2.0%. Risk-standardized 30-day mortality rates after CAS varied from 1.1% to 5.1% (P<0.001 for the difference). Thirteen hospitals had risk-standardized mortality rates that were statistically (P<0.05) higher than the national mean. Conversely, 5 hospitals had risk-standardized mortality rates that were statistically (P<0.05) lower than the national mean. CONCLUSIONS: We used administrative claims to identify several CAS hospitals with excessively high 30-day mortality after carotid stenting. When combined with information currently used by Medicare for CAS recertification, such as clinical registry data and program reports, clinical outcomes comparisons could enhance Medicare's ability to identify hospitals that are questionable candidates for recertification.
Authors: Brahmajee K Nallamothu; Hitinder S Gurm; Henry H Ting; Philip P Goodney; Mary A M Rogers; Jeptha P Curtis; Justin B Dimick; Eric R Bates; Harlan M Krumholz; John D Birkmeyer Journal: JAMA Date: 2011-09-28 Impact factor: 56.272
Authors: William A Gray; L Nelson Hopkins; Sanjay Yadav; Thomas Davis; Mark Wholey; Richard Atkinson; Alberto Cremonesi; Ronald Fairman; Gary Walker; Patrick Verta; Jeff Popma; Renu Virmani; David J Cohen Journal: J Vasc Surg Date: 2006-08 Impact factor: 4.268
Authors: Jeffrey H Silber; Paul R Rosenbaum; Tanguy J Brachet; Richard N Ross; Laura J Bressler; Orit Even-Shoshan; Scott A Lorch; Kevin G Volpp Journal: Health Serv Res Date: 2010-10 Impact factor: 3.402
Authors: Beau M Hawkins; Kevin F Kennedy; Jay Giri; Adam J Saltzman; Kenneth Rosenfield; Douglas E Drachman; Christopher J White; John A Spertus; Robert W Yeh Journal: J Am Coll Cardiol Date: 2012-09-19 Impact factor: 24.094
Authors: Robert W Hobson; Virginia J Howard; Gary S Roubin; Thomas G Brott; Robert D Ferguson; Jeffrey J Popma; Darlene L Graham; George Howard Journal: J Vasc Surg Date: 2004-12 Impact factor: 4.268
Authors: Hitinder S Gurm; Jay S Yadav; Pierre Fayad; Barry T Katzen; Gregory J Mishkel; Tanvir K Bajwa; Gary Ansel; Neil E Strickman; Hong Wang; Sidney A Cohen; Joseph M Massaro; Donald E Cutlip Journal: N Engl J Med Date: 2008-04-10 Impact factor: 91.245
Authors: Christian Lopez Ramos; Michael G Brandel; Robert C Rennert; Brian R Hirshman; Arvin R Wali; Jeffrey A Steinberg; David R Santiago-Dieppa; Mitchell Flagg; Scott E Olson; J Scott Pannell; Alexander A Khalessi Journal: Neurosurgery Date: 2020-02-01 Impact factor: 4.654